Supernus Pharmaceuticals (NASDAQ:SUPN) PT Lowered to $42.00
Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) had its target price trimmed by Piper Sandler from $43.00 to $42.00 in a report published on Wednesday, Benzinga reports. The firm currently has an overweight rating on the specialty pharmaceutical company’s stock. Separately, StockNews.com upgraded shares of Supernus Pharmaceuticals from a hold rating to a buy rating in […]
More Stories
MiL.k (MLK) Price Reaches $0.20
MiL.k (MLK) traded down 0.8% against the dollar during the 1 day period ending at 21:00 PM E.T. on September...
Litecoin Cash Reaches Market Capitalization of $2.62 Million (LCC)
Litecoin Cash (LCC) traded 0.6% higher against the dollar during the twenty-four hour period ending at 21:00 PM Eastern on...
Rally (RLY) Market Capitalization Achieves $30.00 Million
Rally (RLY) traded 0.9% higher against the U.S. dollar during the 24-hour period ending at 21:00 PM ET on September...
Sanctum Infinity Self Reported Market Capitalization Achieves $166.35 Million (INF)
Sanctum Infinity (INF) traded up 2.4% against the US dollar during the 1-day period ending at 21:00 PM E.T. on...
StakeWise Staked ETH (OSETH) Trading 9.6% Lower Over Last Week
StakeWise Staked ETH (OSETH) traded 2.2% higher against the U.S. dollar during the 1 day period ending at 21:00 PM...
Taiko Tops 24 Hour Trading Volume of $14.38 Million (TAIKO)
Taiko (TAIKO) traded 1.9% higher against the U.S. dollar during the 24-hour period ending at 21:00 PM ET on September...